CA
NZ
UK
AU
IND
US
SQZ Biotechnologies was a Massachusetts-based, clinical-stage company developing cell-engineering therapies using its proprietary "Cell Squeeze" platform, which momentarily deforms a cell's membrane to deliver antigens and other cargo, with lead programs in immuno-oncology. The company's most consequential recent development is procedural: SEC records show …
GelStat Corporation, incorporated in Delaware and based in Miami, is classified under pharmaceutical preparations and traces its corporate history back to an entity formerly named Developed Technology Resource Inc before adopting the GelStat name in 2003. Rather than filing standard 10-Ks and 10-Qs, GelStat …
Revelation Biosciences is developing Gemini, a phosphorylated hexaacyl disaccharide (PHAD)-based immunomodulator, with its lead program targeting acute kidney injury (AKI), a common and serious complication with few effective preventive therapies. The most recent verified milestone came on August 19, 2026, when Revelation said it …
Fulcrum Therapeutics is a Cambridge, Massachusetts clinical-stage biopharmaceutical company focused on small-molecule therapies for genetically defined diseases. For years its identity centered on losmapimod, an oral candidate for facioscapulohumeral muscular dystrophy (FSHD). That program suffered a decisive setback when its pivotal Phase 3 trial …
IDEXX Laboratories, based in Maine, is the global leader in veterinary diagnostics and software. Its largest business, the Companion Animal Group, sells in-clinic analyzers and their consumables, rapid SNAP tests and reference-laboratory services, creating a razor-and-blades model in which instrument placements drive years of …
cbdMD, based in Charlotte, North Carolina, markets consumer cannabidiol (CBD) products including tinctures, gummies, capsules and topicals, alongside a pet line under the Paw CBD brand. The company sells through e-commerce and retail channels and has positioned itself around wellness and quality. The most …
Allarity Therapeutics is a clinical-stage oncology company built around its Drug Response Predictor (DRP) platform, a genomic tool designed to select patients most likely to benefit from a given therapy. Its lead asset, stenoparib, is an orally available inhibitor being studied in advanced ovarian …
Aptevo Therapeutics, based in Seattle, is a clinical-stage biotechnology company developing bispecific antibodies through its ADAPTIR and ADAPTIR-FLEX platforms. Its lead candidate, mipletamig, is a T-cell-engaging bispecific designed to target CD123 in acute myeloid leukemia (AML), and the company has reported early clinical activity …
ResMed designs and sells devices and cloud-connected software for sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions, alongside out-of-hospital software businesses. On July 7, 2026, the company announced a definitive agreement to sell MatrixCare, its senior-care electronic-health-record platform, to private-equity firm Frazier …
STAAR Surgical, based in Lake Forest, California, is best known for its EVO Implantable Collamer Lens (ICL), a refractive lens implanted to correct nearsightedness and astigmatism as an alternative to laser vision correction. The defining recent event is regulatory in the corporate sense rather …
Please wait processing your request...